173 related articles for article (PubMed ID: 8140600)
1. The synthesis of 7 alpha-methyl-substituted estrogens labeled with fluorine-18: potential breast tumor imaging agents.
VanBrocklin HF; Liu A; Welch MJ; O'Neil JP; Katzenellenbogen JA
Steroids; 1994 Jan; 59(1):34-45. PubMed ID: 8140600
[TBL] [Abstract][Full Text] [Related]
2. 16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.
VanBrocklin HF; Carlson KE; Katzenellenbogen JA; Welch MJ
J Med Chem; 1993 May; 36(11):1619-29. PubMed ID: 7684451
[TBL] [Abstract][Full Text] [Related]
3. 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals.
Seimbille Y; Rousseau J; Bénard F; Morin C; Ali H; Avvakumov G; Hammond GL; van Lier JE
Steroids; 2002 Aug; 67(9):765-75. PubMed ID: 12123788
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of 17-ethynyl-substituted 16 alpha-[18F]fluoroestradiols: selective receptor-based PET imaging agents.
VanBrocklin HF; Pomper MG; Carlson KE; Welch MJ; Katzenellenbogen JA
Int J Rad Appl Instrum B; 1992 Apr; 19(3):363-74. PubMed ID: 1629026
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, radiolabeling and tissue distribution of 11 beta-fluoroalkyl- and 11 beta-fluoroalkoxy-substituted estrogens: target tissue uptake selectivity and defluorination of a homologous series of fluorine-18-labeled estrogens.
French AN; Napolitano E; VanBrocklin HF; Hanson RN; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 1993 Jan; 20(1):31-47. PubMed ID: 8461878
[TBL] [Abstract][Full Text] [Related]
6. 11 beta-methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alpha-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity.
Pomper MG; VanBrocklin H; Thieme AM; Thomas RD; Kiesewetter DO; Carlson KE; Mathias CJ; Welch MJ; Katzenellenbogen JA
J Med Chem; 1990 Dec; 33(12):3143-55. PubMed ID: 1701833
[TBL] [Abstract][Full Text] [Related]
7. Oxohexestrol derivatives labeled with fluorine-18. Synthesis, receptor binding and in vivo distribution of two non-steroidal estrogens as potential breast tumor imaging agents.
Bergmann KE; Landvatter SW; Rocque PG; Carlson KE; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 1994 Jan; 21(1):25-39. PubMed ID: 9234261
[TBL] [Abstract][Full Text] [Related]
8. Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780).
Seimbille Y; Bénard F; Rousseau J; Pepin E; Aliaga A; Tessier G; van Lier JE
Nucl Med Biol; 2004 Aug; 31(6):691-8. PubMed ID: 15246359
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 7α-(3-[(18)F]fluoropropyl) estradiol.
Okamoto M; Naka K; Kitagawa Y; Ishiwata K; Yoshimoto M; Shimizu I; Toyohara J
Nucl Med Biol; 2015 Jul; 42(7):590-7. PubMed ID: 25823392
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol.
Yoo J; Dence CS; Sharp TL; Katzenellenbogen JA; Welch MJ
J Med Chem; 2005 Oct; 48(20):6366-78. PubMed ID: 16190762
[TBL] [Abstract][Full Text] [Related]
11. Carbon-11-labeled estrogens as potential imaging agents for breast tumors.
Dence CS; Napolitano E; Katzenellenbogen JA; Welch MJ
Nucl Med Biol; 1996 May; 23(4):491-6. PubMed ID: 8832705
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biodistribution of fluorine-18-labeled fluorocyclofenils for imaging the estrogen receptor.
Seo JW; Chi DY; Dence CS; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 2007 May; 34(4):383-90. PubMed ID: 17499727
[TBL] [Abstract][Full Text] [Related]
13. Titration of the in vivo uptake of 16 alpha-[18F]fluoroestradiol by target tissues in the rat: competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical development.
Katzenellenbogen JA; Mathias CJ; VanBrocklin HF; Brodack JW; Welch MJ
Nucl Med Biol; 1993 Aug; 20(6):735-45. PubMed ID: 8401374
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, estrogen receptor binding, and tissue distribution of [18F]fluorodoisynolic acids.
Scribner AW; Jonson SD; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 1997 Apr; 24(3):209-24. PubMed ID: 9228655
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens.
Heiman DF; Senderoff SG; Katzenellenbogen JA; Neeley RJ
J Med Chem; 1980 Sep; 23(9):994-1002. PubMed ID: 7411555
[TBL] [Abstract][Full Text] [Related]
16. PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.
Jonson SD; Welch MJ
Q J Nucl Med; 1998 Mar; 42(1):8-17. PubMed ID: 9646640
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity.
Buckman BO; Bonasera TA; Kirschbaum KS; Welch MJ; Katzenellenbogen JA
J Med Chem; 1995 Jan; 38(2):328-37. PubMed ID: 7830275
[TBL] [Abstract][Full Text] [Related]
18. Comparative breast tumor imaging and comparative in vitro metabolism of 16alpha-[18F]fluoroestradiol-17beta and 16beta-[18F]fluoromoxestrol in isolated hepatocytes.
Jonson SD; Bonasera TA; Dehdashti F; Cristel ME; Katzenellenbogen JA; Welch MJ
Nucl Med Biol; 1999 Jan; 26(1):123-30. PubMed ID: 10096512
[TBL] [Abstract][Full Text] [Related]
19. 16 beta-[18F]fluoromoxestrol: a potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors.
VanBrocklin HF; Rocque PA; Lee HV; Carlson KE; Katzenellenbogen JA; Welch MJ
Life Sci; 1993; 53(10):811-9. PubMed ID: 8355567
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17alpha,20E)-21-[123I]Iodo-11beta-nitrato-19-norp regna-1,3,5 (10),20-tetraene-3,17-diol (E-[123I]NIVE).
Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Doornbos T; Vekemans JA; Posthumus MA; Janssen AG; van Royen EA
Nucl Med Biol; 1998 May; 25(4):411-21. PubMed ID: 9639304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
